Congress Trades
Latest disclosures
| Chamber | Transaction Date | Member | Owner | Asset | Action | Amount | Ticker ▲ | Δ Since Trade |
|---|---|---|---|---|---|---|---|---|
| Senate | Sep. 22, 2022 | John Boozman | Goldman Sachs Access Investment Grade Corporate Bond ETF | SALE | $1,001 - $15,000 | GIGB | ▲ +5.25% | |
| Senate | Oct. 26, 2022 | John Boozman | Goldman Sachs Access Investment Grade Corporate Bond ETF | SALE | $1,001 - $15,000 | GIGB | ▲ +8.96% | |
| Senate | Apr. 27, 2022 | John Boozman | Goldman Sachs Access Investment Grade Corporate Bond ETF | PURCHASE | $1,001 - $15,000 | GIGB | ▼ -1.75% | |
| Senate | Sep. 16, 2025 | John Boozman | Joint | Goldman Sachs Access Investment Grade Corporate Bond ETF | SALE | $1,001 - $15,000 | GIGB | ▼ -1.16% |
| Senate | Aug. 1, 2025 | John Boozman | Joint | Goldman Sachs Access Investment Grade Corporate Bond ETF | SALE | $1,001 - $15,000 | GIGB | ▲ +0.77% |
| Senate | Aug. 1, 2025 | John Boozman | Joint | Goldman Sachs Access Investment Grade Corporate Bo | SALE (PARTIAL) | $1,001 - $15,000 | GIGB | ▲ +0.77% |
| Senate | Jul. 8, 2025 | John Boozman | Joint | Goldman Sachs Access Investment Grade Corporate Bo | PURCHASE | $1,001 - $15,000 | GIGB | ▲ +2.01% |
| Senate | May. 10, 2024 | Tommy Tuberville | Joint | Gilead Sciences Inc | PURCHASE | $1,001 - $15,000 | GILD | ▲ +86.48% |
| Senate | May. 8, 2024 | Tommy Tuberville | Joint | Gilead Sciences, Inc. - Common Stock | SALE (FULL) | $1,001 - $15,000 | GILD | ▲ +89.46% |
| Senate | Apr. 3, 2024 | Tommy Tuberville | Joint | Gilead Sciences, Inc. - Common Stock | SALE (FULL) | $1,001 - $15,000 | GILD | ▲ +73.51% |
| Senate | Apr. 5, 2024 | Tommy Tuberville | Joint | Gilead Sciences, Inc. - Common Stock | PURCHASE | $1,001 - $15,000 | GILD | ▲ +76.77% |
| Senate | Jan. 13, 2022 | Tommy Tuberville | Joint | Gilead Sciences, Inc. - Common Stock | SALE (FULL) | $1,001 - $15,000 | GILD | ▲ +71.12% |
| Senate | Dec. 21, 2021 | Jerry Moran | Spouse | Gilead Sciences, Inc. - Common Stock | SALE (FULL) | $1,001 - $15,000 | GILD | ▲ +71.21% |
| Senate | Sep. 25, 2019 | Jerry Moran | Spouse | Gilead Sciences, Inc. | PURCHASE | $1,001 - $15,000 | GILD | ▲ +91.59% |
| Senate | Sep. 25, 2019 | Jerry Moran | Spouse | Gilead Sciences, Inc. | PURCHASE | $1,001 - $15,000 | GILD | ▲ +91.59% |
| House | Sep. 23, 2025 | Val Hoyle | Spouse | Gilead Sciences Inc | SALE | $1,001 - $15,000 | GILD | ▲ +7.52% |
| House | Mar. 7, 2025 | Josh Gottheimer | Joint | Gilead Sciences Inc | PURCHASE | $1,001 - $15,000 | GILD | ▲ +4.76% |
| House | Mar. 31, 2025 | Jefferson Shreve | Gilead Sciences Inc | PURCHASE | $15,001 - $50,000 | GILD | ▲ +9.77% | |
| House | Oct. 29, 2024 | Valerie Hoyle | Spouse | Gilead Sciences, Inc. - Common Stock | PURCHASE | $1,001 - $15,000 | GILD | ▲ +39.65% |
| House | May. 14, 2025 | Josh Gottheimer | Joint | Gilead Sciences Inc | SALE | $1,001 - $15,000 | GILD | ▲ +25.03% |
| House | Mar. 25, 2024 | Ro Khanna | Gilead Sciences Inc | PURCHASE | $1,001 - $15,000 | GILD | ▲ +69.47% | |
| Senate | Mar. 11, 2019 | Shelley Moore Capito | Spouse | Gilead Sciences, Inc. | SALE (FULL) | $1,001 - $15,000 | GILD | ▲ +91.17% |
| Senate | Sep. 25, 2018 | Shelley Moore Capito | Self | Gilead Sciences, Inc. | PURCHASE | $1,001 - $15,000 | GILD | ▲ +64.02% |
| House | Jun. 6, 2025 | Marjorie Taylor Greene | Gilead Sciences Inc | PURCHASE | $1,001 - $15,000 | GILD | ▲ +9.37% | |
| House | May. 5, 2025 | Marjorie Taylor Greene | Gilead Sciences Inc (2) | PURCHASE | $1,001 - $15,000 | GILD | ▲ +19.64% | |
| House | Mar. 10, 2025 | Carol Devine Miller | Gilead Sciences, Inc. - Common Stock | PURCHASE | $1,001 - $15,000 | GILD | ▲ +4.94% | |
| Senate | Sep. 20, 2017 | Sheldon Whitehouse | Spouse | Gilead Sciences, Inc. | SALE (FULL) | $1,001 - $15,000 | GILD | ▲ +66.19% |
| House | Dec. 24, 2024 | Marjorie Taylor Greene | Gilead Sciences Inc | PURCHASE | $1,001 - $15,000 | GILD | ▲ +30.92% | |
| Senate | Aug. 21, 2020 | Jerry Moran | Self | Gilead Sciences, Inc. | PURCHASE | $1,001 - $15,000 | GILD | ▲ +84.96% |
| Senate | Apr. 23, 2018 | Angus King | Spouse | Gilead Sciences, Inc. | SALE (PARTIAL) | $1,001 - $15,000 | GILD | ▲ +66.19% |
Last updated: Nov 5, 00:24